Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 7, 2010, Pages 1235-1242

  Younes, Naji ^a   Cleary, Patricia A ^a   Steffes, Michael W ^b   De Boer, Ian H ^c   Molitch, Mark E ^d   Rutledge, Brandy N ^a   Lachin, John M ^a   Dahms, William ^e  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLYCOSYLATED HEMOGLOBIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ARTICLE; COMPARATIVE STUDY; DIABETIC PATIENT; EXCRETION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MUSCLE MASS; PREVALENCE; STANDARDIZATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 1; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SEX DIFFERENCE; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES; URINE;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77954799759     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07901109     Document Type: Article

References (28)

1. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. JAMA 290: 2159-2167, 2003
2. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type 1 diabetes as the prevalence of stages of diabetic nephropathy defined by urinary/albumin creatinine ratio. J Am Soc Nephrol 7: 930-937, 1996 (Pubitemid 27465988)
3. Ginsberg JM, Chang BS, Matarese RA, Garella S: Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309: 1543-1546, 1983
4. Nathan DM, Rosenbaum C, Protasowiski D: Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10: 414-418, 1987 (Pubitemid 17133602)
5. Dunn PJ, Jury DR: Random urine albumin:creatinine ratio measurements as a screening test for diabetic microalbuminuria: A five year follow up. N Z Med J 103: 562-564, 1990
6. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH: Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 151: 1761-1765, 1991
7. Dyer AR, Greenland P, Elliott P, Daviglus ML, Claeys G, Kesteloot H, Ueshima H, Stamler J: INTERMAP Research Group: Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 160: 1122-1131, 2004 (Pubitemid 39557465)
8. Jacobs DR Jr, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC: Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 155: 1114-1119, 2002 (Pubitemid 34625500)
9. Diabetes Control and Complications Trial (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 309: 977-981, 1993
10. Diabetes Control and Complications Trial (DCCT) Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703-1720, 1995
11. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22: 99-111, 1999
12. Bland J, Altman D: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986 (Pubitemid 16134762)
13. Cleveland WS, Devlin SJ: Locally weighted regression: An approach to regression analysis by local fitting. J Am Statist Assoc 83: 596-610, 1988
14. Levey A, Bosch J, Breyer Lewis JB, Greene T, Rogers N, Roth D: A more accurate method of estimate glomerular filtration rate from serum creatinine. Ann Intern Med 130: 461-470, 1999
15. Cohen J: A coefficient of agreement for nominal scales. Educational and Psychological Measurement 20: 37-46, 1960
16. Efron B, Tibshirani R: An Introduction to the Bootstrap, London, England, Chapman & Hall/CRC, 1994
17. Hunter A: Creatine and Creatinine, Monographs on Biochemistry, New York, Longmans, Green, and Co., Ltd., 1928
18. Hahn A, Meyer G: On the mutual transformation of creatine and creatinine. Z Biol 78: 111-115, 1928
19. Dominguez R, Pomerene E: Recovery of creatinine after ingestion and after intravenous injection in man. Proc Soc Exp Biol Med 32: 26-28, 1928
20. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S: Measurement of muscle mass in humans: Validity of the 24-hour urinary creatinine method. Am J Clin Nutr 37: 478-494, 1983 (Pubitemid 13086433)
21. Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 13: 1034-1039, 2002 (Pubitemid 34274100)
22. Kramer HJ, Nguyen QD, Curhan G, Hsu CY: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289: 3273-3277, 2003 (Pubitemid 37430080)
23. de Boer IH, Astor BC, Kramer H, Palmas W, Rudser K, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B: Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 197: 407-414, 2008
24. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS: 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50: 69-77, 2007
25. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS: Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 55: 24-38, 2009
26. Vermes I, Spooren PF: Influence of biological variations and sample handling on measured microalbuminuria in diabetic patients. J Clin Lab Anal 6: 368-374, 1992
27. Howey JE, Browning MC, Fraser CG: Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: Novel uses of data on biological variation. Clin Chem 33: 2034-2038, 1987
28. Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort R: First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol 20: 436-443, 2009